Skip to content
Screener

Medtronic MDT Q3 2026 earnings

Reported February 17, 2026 · Before market open

Revenue$9.0BBeat by $106.1M
EPS$1.36Beat by $0.02
Revenue estimate$8.9B
EPS estimate$1.34

Next report

Sep 1, 2026 (In 4 days)
Revenue estimate$9.5B
EPS estimate$1.39

Financials

Q3 2026

Income statement

See full
Revenue$9.0B+8.7%
Gross profit$5.8B+4.4%
Operating income$1.5B-11.1%
Net income$1.1B-11.7%
EPS (diluted)$0.89-11.9%

Balance sheet

See full
Cash & equivalents$1.1B-7.5%
Total debt$28.1B+5.5%
Total equity$49.0B-0.8%
Total assets$91.5B+1.7%

Cash flow

See full
Operating cash flow$2.7B+6.7%
CapEx$444.0M-6.7%
Free cash flow$2.3B+9.7%

Valuation & ratios

Valuation

as of 01/23/26
See full
Market cap$132B+13.3%
Enterprise value$158.98B+12.1%
P/E28.6×+1.3×
P/S3.7×+0.2×

Profitability

See full
Gross margin64.9%-0.4pp
Operating margin17%+0.2pp
Net margin13%+0.2pp
FCF margin15.2%-1.2pp

Returns & leverage

See full
Return on equity9.4%+1.0pp
Debt / equity0.6×0.0×
Current ratio2.5×+0.6×

Segments

By segment

See full
Cardiovascular$3.5B+13.8%
Neuroscience$2.6B+4.1%
Medical Surgical$2.2B+4.9%
Diabetes$796.0M+14.7%
Other operating segment$32.0M0.0%

FAQ

When did Medtronic report Q3 2026 earnings?
Medtronic (MDT) reported Q3 2026 earnings on February 17, 2026 before market open.
What were Medtronic's Q3 2026 revenue and EPS?
Medtronic reported revenue of $9.0B and eps of $1.36 for Q3 2026.
Did Medtronic beat estimates in Q3 2026?
Revenue beat the consensus estimate of $8.9B by $106.1M. EPS beat the consensus estimate of $1.34 by $0.02.
How did Medtronic's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.7% from $8.3B a year earlier and eps declined 2.2% from $1.39.
Where can I find Medtronic's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-008300) and the 10-Q periodic report (0001628280-26-011107) directly on SEC EDGAR. The filing index links above go to sec.gov.